Latest Period
Q1 2026
Security Snapshot
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) Institutional Ownership
CUSIP: 88025U109
13F Institutional Holders and Ownership History from Q3 2019 to Q1 2026
Institutions Reporting
328
Shares (Excl. Options)
125,180,795
Price
$21.23
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / CLASS A COMMON STOCK
- Symbol
- TXG on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 125,180,795
- Total 13F value
- $2,655,352,368
- Portfolio coverage rank
- 0.01%
- Share change
- +1,724,194
- Value change
- +$60,398,882
- Number of holders
- 328
- Shares outstanding
- 118,868,985
- SEC-reported price per share
- $22.43
- Insider filing price
- $22.43
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK is tracked under CUSIP 88025U109.
- 328 institutions reported positions in Q1 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 320 to 328 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $2,012,781,143 to $2,655,352,368.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 328 institutions filings for Q1 2026.
Security key
88025U109
Latest holder period
Q1 2026
13F holders
328
13D/G owners
7
CIK / CUSIP context first
Open Q1 2026 holders
TXG full holder history
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
10x Genomics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88025U109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
TXG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 16% | +44% | $355,109,205 | +$111,975,948 | 18,543,562 | +46% | FMR LLC | 27 Feb 2026 |
| VANGUARD GROUP INC | 12% | $155,176,941 | 13,274,332 | The Vanguard Group | 30 Sep 2025 | |||
| ARK Investment Management LLC | 10% | -12% | $138,963,659 | -$11,202,726 | 11,887,396 | -7.5% | ARK Investment Management LLC | 30 Sep 2025 |
| BlackRock, Inc. | 7.6% | $98,391,045 | 8,496,636 | BlackRock, Inc. | 30 Jun 2025 | |||
| Sumitomo Mitsui Trust Group, Inc. | 4.7% | -14% | $62,906,450 | -$7,397,081 | 5,381,219 | -11% | Sumitomo Mitsui Trust Group, Inc. | 30 Sep 2025 |
| Amova Asset Management Americas, Inc. | 4.7% | -14% | $62,855,762 | -$7,397,081 | 5,376,883 | -11% | Amova Asset Management Americas, Inc. | 30 Sep 2025 |
| MILLENNIUM MANAGEMENT LLC | 2.7% | -48% | $36,913,960 | -$29,821,474 | 3,060,859 | -45% | Millennium Management LLC | 30 Jun 2025 |
As of 31 Mar 2026, 328 institutional investors reported holding 125,180,795 shares of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG). This represents 105% of the company’s total 118,868,985 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
84%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 17,740,972 | +49% | 0.02% | $376,640,828 |
| ARK Investment Management LLC | 9.9% | 11,717,317 | -7.5% | 1.9% | $248,758,647 |
| BlackRock, Inc. | 8.5% | 10,079,913 | +0.65% | 0% | $213,996,552 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.8% | 6,912,936 | 0% | 0.01% | $146,761,631 |
| Quantinno Capital Management LP | 4.6% | 5,411,761 | +16% | 0.19% | $114,891,686 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 5,269,586 | 0% | 0% | $111,873,311 |
| Sumitomo Mitsui Trust Group, Inc. | 4.3% | 5,110,214 | -7% | 0.07% | $108,489,843 |
| Amova Asset Management Americas, Inc. | 4.3% | 5,104,178 | -7% | 1.5% | $108,310,657 |
| GOLDMAN SACHS GROUP INC | 3.3% | 3,971,800 | +29% | 0.01% | $84,321,314 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 2,904,228 | +4.1% | 0% | $61,669,469 |
| MORGAN STANLEY | 2.2% | 2,656,353 | -17% | 0% | $56,394,400 |
| STATE STREET CORP | 2.2% | 2,588,795 | +3% | 0% | $54,960,118 |
| AQR CAPITAL MANAGEMENT LLC | 2.1% | 2,538,256 | -1.6% | 0.02% | $53,658,731 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.9% | 2,283,424 | -14% | 0.2% | $48,477,092 |
| Casdin Capital, LLC | 1.9% | 2,275,000 | +62% | 3.7% | $48,298,250 |
| MILLENNIUM MANAGEMENT LLC | 1.7% | 2,068,414 | +66% | 0.03% | $43,912,429 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 2,042,950 | +35% | 0.01% | $43,356,785 |
| Capital World Investors | 1.2% | 1,452,300 | 0% | 0% | $30,832,329 |
| T. Rowe Price Investment Management, Inc. | 1.1% | 1,279,382 | -0.01% | 0.02% | $27,162,000 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.95% | 1,127,056 | +1.9% | 0% | $23,927,399 |
| Blue Water Life Science Advisors, LP | 0.92% | 1,090,000 | 19% | $23,140,700 | |
| NORTHERN TRUST CORP | 0.88% | 1,048,005 | +5.5% | 0% | $22,249,147 |
| RENAISSANCE TECHNOLOGIES LLC | 0.85% | 1,008,739 | -35% | 0.03% | $21,415,529 |
| Balyasny Asset Management L.P. | 0.83% | 989,522 | 0.04% | $21,007,552 | |
| BANK OF AMERICA CORP /DE/ | 0.81% | 964,579 | -48% | 0% | $20,478,002 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
27
Latest
Q1 2026
Rows shown
1-25 of 27
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 125,180,795 | $2,655,352,368 | +$60,398,882 | $21.23 | 328 |
| 2025 Q4 | 123,358,813 | $2,012,781,143 | +$17,019,168 | $16.31 | 320 |
| 2025 Q3 | 122,930,411 | $1,437,019,448 | +$5,456,573 | $11.69 | 313 |
| 2025 Q2 | 122,631,794 | $1,420,549,489 | +$119,573,048 | $11.58 | 293 |
| 2025 Q1 | 113,813,127 | $993,375,835 | +$50,874,984 | $8.73 | 269 |
| 2024 Q4 | 104,507,907 | $1,500,773,196 | -$41,937,351 | $14.36 | 270 |
| 2024 Q3 | 104,345,431 | $2,355,358,198 | -$6,296,831 | $22.58 | 258 |
| 2024 Q2 | 105,353,108 | $2,048,895,776 | +$7,101,276 | $19.45 | 254 |
| 2024 Q1 | 102,897,655 | $3,861,610,085 | +$222,058,012 | $37.53 | 280 |
| 2023 Q4 | 95,956,168 | $5,370,151,466 | +$202,330,286 | $55.96 | 267 |
| 2023 Q3 | 90,883,461 | $3,748,861,587 | +$66,054,684 | $41.25 | 252 |
| 2023 Q2 | 89,127,845 | $4,977,465,562 | -$57,613,061 | $55.84 | 269 |
| 2023 Q1 | 90,187,979 | $5,027,414,812 | +$211,396,981 | $55.79 | 255 |
| 2022 Q4 | 87,545,856 | $3,190,400,302 | +$104,674,768 | $36.44 | 253 |
| 2022 Q3 | 86,068,255 | $2,449,753,227 | -$43,840,073 | $28.48 | 208 |
| 2022 Q2 | 86,085,516 | $3,909,380,180 | +$83,806,084 | $45.25 | 228 |
| 2022 Q1 | 82,769,403 | $6,293,794,627 | -$74,133,769 | $76.07 | 286 |
| 2021 Q4 | 79,764,587 | $11,861,468,865 | +$65,047,101 | $148.96 | 347 |
| 2021 Q3 | 78,759,967 | $11,461,957,413 | +$127,530,777 | $145.58 | 317 |
| 2021 Q2 | 77,884,791 | $15,246,137,868 | +$1,517,689,271 | $195.82 | 332 |
| 2021 Q1 | 70,505,001 | $12,760,866,584 | +$832,242,795 | $181.00 | 310 |
| 2020 Q4 | 66,229,914 | $9,377,686,882 | -$749,751,524 | $141.60 | 299 |
| 2020 Q3 | 69,088,795 | $8,545,655,879 | +$1,071,434,021 | $124.68 | 215 |
| 2020 Q2 | 61,004,107 | $5,448,595,110 | +$1,160,387,284 | $89.31 | 141 |
| 2020 Q1 | 38,929,050 | $2,426,163,019 | +$612,574,707 | $62.32 | 102 |